Active Ingredient: METRONIDAZOLE
Proprietary Name: LIKMEZ
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 500MG/5ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N216755
Product Number: 001
Approval Date: Sep 22, 2023
Applicant Holder Full Name: SAPTALIS PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information
